am doses of the vaccine, 21 days apart. It is worth noting that the dose for children over 12 years of age is 30 micrograms.
The results indicate that their COVID-19 vaccine is safe, as it generates a robust and well-tolerated immune response. According to Pfizer and BioNTech, the immune response obtained is comparable to that observed in volunteers aged 16 to 25 who comprised the control group in this trial. The same is true for side effects, which were also comparable to those identified in the 16-to-25-year-old group.
Covid-19
HealthNews
Given these encouraging results, Pfizer and BioNTech stated that they were “eager to extend the protection offered by the vaccine
